Contact
Home
Sitemap
Careers
About Us
Corporate Overview
Executive Management
Scientific Advisory Board
Careers
Pipeline
Pipeline Overview
Azedra™
Onalta™
Solazed™
Trofex™
Molecular Medicine
Molecular Medicine Overview
Targeted Radiotherapeutics
Molecular Imaging Pharmaceuticals
Proprietary Technologies
Scientific Presentations
Scientific Posters
Bibliography
In The Clinic
Clinical Trials Overview
Oncology Trials
Cardiovascular Trials
Patient Resources
Media Room
Media Room Overview
Press Releases
Glossary
Scientific Presentations
Scientific Posters
Bibliography
Media Room
Media Room Overview
Press Releases
Archive
Glossary
Scientific Presentations
Scientific Posters
Bibliography
Media Room
>>
Press Releases
>>
Archive
Archive
2007
|
2006
|
2005
|
2004
|
2003
2007
Date
Publication
11/12/07
Molecular Insight Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
11/09/07
Molecular Insight Pharmaceuticals, Inc. Prices $150 Million Bond Financing
11/05/07
Molecular Insight Pharmaceuticals, Inc. To Announce Third Quarter Financial Results On November 12, 2007
10/25/07
Molecular Insight Pharmaceuticals, Inc. Presents Preclinical TrofexTM Prostate Cancer Data at AACR
10/18/07
Molecular Insight Pharmaceuticals, Inc. Announces Positive Results of AzedraTM Phase 1 Dosimetry Trial for Neuroendocrine Tumors
10/03/07
Molecular Insight Pharmaceuticals, Inc. Completes Strategic Purchase of Radiopharmaceutical Manufacturing Facility
09/19/07
Molecular Insight Pharmaceuticals, Inc. To Present at 2007 UBS Global Life Sciences Conference
09/11/07
Molecular Insight Pharmaceuticals, Inc. to Host Conference Call to Review Positive ZemivaTM Phase 2b Data Presented at ASNC
09/10/07
Molecular Insight Pharmaceuticals, Inc. Announces Positive Results of Pilot Investigation of ZemivaTM in Emergency Department Setting
09/07/07
ZemivaTM Normals Database From Molecular Insight Pharmaceuticals, Inc. Enables Accurate Determination of Abnormal Heart Activity
08/29/07
Molecular Insight Pharmaceuticals, Inc. To Present At NewsMakers In The Biotech Industry Conference
08/21/07
Former FDA Deputy Commissioner Scott Gottlieb, M.D. joins Molecular Insight Pharmaceuticals, Inc. Board of Directors
08/16/07
Molecular Insight Pharmaceuticals, Inc. Announces Appointment of Donald E. Wallroth as Chief Financial Officer
08/13/07
Molecular Insight Pharmaceuticals, Inc. Announces Second Quarter 2007 Financial Results
08/06/07
Molecular Insight Pharmaceuticals, Inc. To Announce Second Quarter Financial Results On August 13, 2007
08/06/07
Molecular Insight Pharmaceuticals, Inc. Selected to Present Zemiva™ Phase 2b Clinical Trial Data in Late Breaking Clinical Forum at American Society of Nuclear Cardiology Annual Meeting
06/25/07
Molecular Insight Pharmaceuticals, Inc. Initiates First of Two Planned Pivotal Registration Trials for Zemiva™ in Detection of Cardiac Ischemia
06/20/07
Molecular Insight Pharmaceuticals, Inc. To Present At Jefferies Healthcare Conference
06/04/07
Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
06/04/07
Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
05/17/07
Molecular Insight Pharmaceuticals, Inc. Enters into Agreement to Purchase Radiopharmaceutical Manufacturing Facility
05/15/07
Molecular Insight Pharmaceuticals, Inc. Announces First Quarter 2007 Financial Results
05/10/07
Molecular Insight Pharmaceuticals, Inc. Initiates Azedra™ Therapeutic Trial in Neuroendocrine Cancer Patients
05/09/07
Molecular Insight Pharmaceuticals, Inc. to Host Conference Call on May 15
05/01/07
Molecular Insight Pharmaceuticals, Inc. Announces Participation in Sessions at BIO 2007 International Convention
04/23/07
Molecular Insight Pharmaceuticals, Inc. Announces Appointment of Norman LaFrance, M.D., as Senior Vice President, Clinical Development and Chief Medical Officer
04/18/07
Molecular Insight Pharmaceuticals, Inc. Announces Appointment of Brian Abeysekera, Ph.D., as Vice President, Manufacturing
04/13/07
Molecular Insight Pharmaceuticals, Inc. Announces Resignation of Chief Financial Officer
02/02/07
Molecular Insight Pharmaceuticals, Inc. Announces Initial Public Offering
01/24/07
Molecular Insight Pharmaceuticals, Inc. Acquires Clinical Stage, Targeted Radiotherapeutic Candidate Onalta™ (Formerly OctreoTher™)
01/17/07
Molecular Insight Pharmaceuticals, Inc. Acquires Malignant Melanoma Radiotherapeutic Drug Candidate from Bayer Schering Pharma
2006
Date
Publication
06/22/06
Molecular Insight Pharmaceuticals, Inc. Initiates Azedra™ Phase 1 Clinical Trial for Treatment of Neuroendocrine Cancer
06/07/06
Molecular Insight Pharmaceuticals, Inc. Presents Azedra™ (Ultratrace™ MIBG) Preclinical Data at Society of Nuclear Medicine Meeting
05/31/06
Molecular Insight Pharmaceuticals' SAAC™ Technology Data Published in Bioconjugate Chemistry
04/12/06
David M. Stack Joins Board of Directors of Molecular Insight Pharmaceuticals, Inc.
03/27/06
Molecular Insight Pharmaceuticals, Inc. Begins Phase 2 Zemiva™ Trial for Compilation of Normal Cardiac Images
02/16/06
Molecular Insight Pharmaceuticals, Inc. and MDS Nordion Enter Manufacturing Agreement for Cardiac Molecular Imaging Pharmaceutical Zemiva™
02/08/06
Molecular Insight Pharmaceuticals, Inc. Receives Orphan Drug Designation for Ultratrace™ MIBG for Treatment of Neuroendocrine Tumors
2005
Date
Publication
11/08/05
Molecular Insight Pharmaceuticals, Inc. Files Registration Statement For Proposed Initial Public Offering
09/26/05
Molecular Insight Pharmaceuticals Announces Publication of Phase 2a Zemiva™ (BMIPP) Trial Results in Circulation
08/18/05
Molecular Insight Expands Executive Research and Development Team
07/21/05
Molecular Insight Pharmaceuticals Announces Management Additions
06/21/05
FierceBiotech Honors Molecular Insight Pharmaceuticals as One of the "Fierce 15" Biotech Companies of 2005
06/01/05
Molecular Insight Pharmaceuticals Appoints Two New Vice Presidents, James Wachholz and Joshua Hamermesh
04/21/05
Molecular Insight Pharmaceuticals Raises $28 Million to Advance Cardiac Ischemia Imaging Pharmaceutical into Phase 3 Trials
2004
Date
Publication
08/26/04
Molecular Insight Pharmaceuticals and University of Maryland Share NIH Grant
07/21/04
New Fluorescence-Based Technology Allows Visualization of Cellular Activity of Molecular Imaging Pharmaceutical Candidates
06/29/04
Molecular Insight Pharmaceuticals Augments Research and Development Capability with Key Hire and Appointment of Two New Board Members
06/22/04
Prostate Tumor Angiogenesis Successfully Targeted by Radiopharmaceutical Designed for Diagnosis and Treatment
06/17/04
MDS Nordion to manufacture Molecular Insight’s lead molecular imaging pharmaceutical
05/20/04
Molecular Insight Pharmaceuticals, Inc. Completes Series B Financing
2003
Date
Publication
10/16/03
Molecular Insight Pharmaceuticals Awarded Three NIH Grants
06/19/03
Molecular Insight Pharmaceuticals, Inc. Names New CEO